Impact of 5-Alpha-Reductase Inhibitors Use at the Time of Prostatic Artery Embolization for Treatment of Benign Prostatic Obstruction
Carregando...
Citações na Scopus
8
Tipo de produção
article
Data de publicação
2019
Título da Revista
ISSN da Revista
Título do Volume
Editora
ELSEVIER SCIENCE INC
Citação
JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, v.30, n.2, p.228-232, 2019
Resumo
Purpose: To compare the 12-month post-prostatic artery embolization (PAE) clinical outcomes of patients who were and were not taking 5-alpha-reductase inhibitors (5ARIs) at the time of PAE. Materials and Methods: A retrospective review was conducted of patients who underwent PAE from 2010 to 2017 due to lower urinary tract symptoms, secondary to benign prostatic hyperplasia (BPH). One hundred fifty-five patients were included and divided in 2 groups; these groups did not present statistically significant differences in their baseline characteristics-those taking 5ARIS (Y-5ARIs, n = 40) and those not taking 5ARIs (N-5ARIs, n = 115). International Prostate Symptom Score (IPSS), the sub-item Quality of Life (QoL), and the incidence of clinical failure were used as primary endpoints. Secondary endpoints included mean prostate volume reduction and mean peak flow rate (Q(max)) improvement. Clinical failure or recurrence was defined as absence of symptomatic improvement (IPSS >= 8 or QoL >= 3) or the need for invasive BPH treatment (PAE or transurethral resection of the prostate) during the 12-month follow-up period. Results: After 12-month follow-up, IPSS, QoL, and prostatic volume were significantly lower compared to baseline in both groups, and Q(max) showed a significant increase. No statistically significant differences were observed in outcomes between N-5ARIs and Y-5ARIs, and the clinical failure rate for both groups was approximately 20%. Conclusions: The use of 5ARIs did not show a detrimental effect on clinical outcomes of PAE, in either subjective (IPSS, QoL, and clinical failure) or objective (prostatic volume and Q(max)) parameters.
Palavras-chave
Referências
- American Urological Association, 2010, MAN BEN PROST HYP
- Andriole G, 2004, J UROLOGY, V172, P1399, DOI 10.1097/01.ju.0000139539.94828.29
- Bansal A, 2017, J ENDOUROL, V31, P910, DOI 10.1089/end.2016.0696-rev
- Burchardt M, 2000, PROSTATE, V43, P184, DOI 10.1002/(SICI)1097-0045(20000515)43:3<184::AID-PROS4>3.0.CO;2-6
- Carnevale FC, 2016, CARDIOVASC INTER RAD, V39, P44, DOI 10.1007/s00270-015-1202-4
- Carnevale FC, 2013, CARDIOVASC INTER RAD, V36, P1452, DOI 10.1007/s00270-013-0680-5
- Carnevale FC, 2017, CARDIOVASC INTER RAD, V40, P366, DOI 10.1007/s00270-017-1569-5
- Clark RV, 2004, J CLIN ENDOCR METAB, V89, P2179, DOI 10.1210/jc.2003-030330
- de Assis AM, 2015, J VASC INTERV RADIOL, V26, P87, DOI 10.1016/j.jvir.2014.10.012
- Gao YA, 2014, RADIOLOGY, V270, P920, DOI 10.1148/radiol.13122803
- Goncalves OM, 2016, CARDIOVASC INTER RAD, V39, P1372, DOI 10.1007/s00270-016-1443-x
- Gravas S, 2016, EUROPEAN ASS UROLOGY, P1
- Hochberg DA, 2002, J UROLOGY, V167, P1731, DOI 10.1016/S0022-5347(05)65188-9
- Kurbatov D, 2014, UROLOGY, V84, P400, DOI 10.1016/j.urology.2014.04.028
- Lekas E, 2000, BJU INT, V85, P962, DOI 10.1046/j.1464-410x.2000.00671.x
- Naslund MJ, 2007, CLIN THER, V29, P17, DOI 10.1016/j.clinthera.2007.01.018
- Pareek G, 2003, J UROLOGY, V169, P20, DOI 10.1097/01.ju.0000039923.75777.91
- Pisco J, 2013, RADIOLOGY, V266, P668, DOI 10.1148/radiol.12111601
- Ray AF, 2018, BJU INT, V122, P270, DOI 10.1111/bju.14249
- Rittmaster RS, 1996, J CLIN ENDOCR METAB, V81, P814, DOI 10.1210/jc.81.2.814
- Uflacker A, 2016, J VASC INTERV RADIOL, V27, P1686, DOI 10.1016/j.jvir.2016.08.004
- Wang MQ, 2016, BJU INT, V117, P155, DOI 10.1111/bju.13147
- Worthington-Kirsch Robert L, 2002, Tech Vasc Interv Radiol, V5, P17, DOI 10.1053/tvir.2002.124101
- Zhu YP, 2015, BMC UROL, V15, DOI 10.1186/s12894-015-0043-4
- Zong HT, 2011, ASIAN J ANDROL, V13, P812, DOI 10.1038/aja.2011.86
Coleções
Artigos e Materiais de Revistas Científicas - FM/MCG
Artigos e Materiais de Revistas Científicas - FM/MDR
Artigos e Materiais de Revistas Científicas - HC/ICESP
Artigos e Materiais de Revistas Científicas - HC/InCor
Artigos e Materiais de Revistas Científicas - HC/InRad
Artigos e Materiais de Revistas Científicas - LIM/44
Carregar mais Artigos e Materiais de Revistas Científicas - FM/MDR
Artigos e Materiais de Revistas Científicas - HC/ICESP
Artigos e Materiais de Revistas Científicas - HC/InCor
Artigos e Materiais de Revistas Científicas - HC/InRad
Artigos e Materiais de Revistas Científicas - LIM/44